Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus

被引:49
作者
Roldan, CA
Gelgand, EA
Qualls, CR
Sibbitt, WL
机构
[1] Vet Affairs Med Ctr, Div Cardiol, Albuquerque, NM 87108 USA
[2] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87108 USA
关键词
D O I
10.1016/j.amjcard.2005.02.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thirty-seven patients with systemic lupus erythematosus underwent complete clinical and laboratory evaluations, including antiphospholipid antibodies and lupus anticoagulant, magnetic resonance imaging of the brain, and transesophageal echocardiography. Cerebrovascular disease manifested as stroke, transient ischemic attack, or cerebral infarcts in patients with nonfocal neurologic deficits was detected in 19 patients (51%), and significant left-sided valvular heart disease in 25 (68%). Valve vegetations, valve thickening, valve regurgitation, and lupus anticoagulant antibody occurred 2 to 3 times more often in patients with than without cerebrovascular disease (all p <= 0.04) and were the only independent predictors of cerebrovascular disease (odd ratios 5.3 to 10.6, all p <= 0.03). Thus, valvular heart disease probably exacerbated by hypercoagulability appears to be a source of embolic ischemic brain injury and cerebrovascular disease. (c) 2005 by Excerpta Medica Inc.
引用
收藏
页码:1441 / 1447
页数:7
相关论文
共 29 条
[1]  
ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259
[2]   NONBACTERIAL THROMBOTIC ENDOCARDITIS - ASSESSMENT BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY [J].
BLANCHARD, DG ;
ROSS, RS ;
DITTRICH, HC .
CHEST, 1992, 102 (03) :954-956
[3]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[4]  
Cook RJ, 2000, J RHEUMATOL, V27, P1892
[5]   Quantitative assessment of valve thickness in normal subjects by transesophageal echocardiography [J].
Crawford, MH ;
Roldan, CA .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (12) :1419-1423
[6]   CLINICAL AND NEUROPATHOLOGICAL FINDINGS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - THE ROLE OF VASCULITIS, HEART EMBOLI, AND THROMBOTIC THROMBOCYTOPENIC PURPURA [J].
DEVINSKY, O ;
PETITO, CK ;
ALONSO, DR .
ANNALS OF NEUROLOGY, 1988, 23 (04) :380-384
[7]   CENTRAL NERVOUS-SYSTEM INVOLVEMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS - REVIEW OF NEUROPATHOLOGIC FINDINGS IN 57 CASES, 1955-1977 [J].
ELLIS, SG ;
VERITY, MA .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1979, 8 (03) :212-221
[8]   INTRAMURAL PLATELET DEPOSITION IN CEREBRAL VASCULOPATHY OF SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ELLISON, D ;
GATTER, K ;
HERYET, A ;
ESIRI, M .
JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (01) :37-40
[9]   EFFECTIVE MITRAL REGURGITANT ORIFICE AREA - CLINICAL USE AND PITFALLS OF THE PROXIMAL ISOVELOCITY SURFACE-AREA METHOD [J].
ENRIQUEZSARANO, M ;
MILLER, FA ;
HAYES, SN ;
BAILEY, KR ;
TAJIK, AJ ;
SEWARD, JB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (03) :703-709
[10]   CEREBRAL EMBOLISM IN LIBMAN-SACKS ENDOCARDITIS [J].
FOX, IS ;
SPENCE, AM ;
WHEELIS, RF ;
HEALEY, LA .
NEUROLOGY, 1980, 30 (05) :487-491